392 related articles for article (PubMed ID: 7694215)
1. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
[TBL] [Abstract][Full Text] [Related]
2. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
[TBL] [Abstract][Full Text] [Related]
3. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Sancken U; Bartels I
Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
5. [Increased AFP in maternal serum as an indication for invasive diagnosis].
Gremm B; Sohn C; Beldermann F; Bastert G
Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
[TBL] [Abstract][Full Text] [Related]
6. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
Grau P; Robinson L; Tabsh K; Crandall BF
Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
[TBL] [Abstract][Full Text] [Related]
8. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
[TBL] [Abstract][Full Text] [Related]
9. Uterine malformation: a cause of elevated maternal serum alpha-fetoprotein concentrations.
Heinonen S; Ryynänen M; Kirkinen P; Saarikoski S
Prenat Diagn; 1996 Jul; 16(7):635-9. PubMed ID: 8843473
[TBL] [Abstract][Full Text] [Related]
10. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein in diabetic pregnancy. A reassessment.
Tharakan T; Baxi L; Kramer D; Anderson R
J Reprod Med; 1993 Dec; 38(12):952-4. PubMed ID: 7509876
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid alpha fetoprotein (AFAFP) and maternal serum alpha fetoprotein (MSAFP) in abdominal pregnancies: correlation with extent and site of placental implantation and clinical implications.
Shumway JB; Greenspoon JS; Khouzami AN; Platt LD; Blakemore KJ
J Matern Fetal Med; 1996; 5(3):120-3. PubMed ID: 8796780
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
14. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI
Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic use of meternal serum alpha-fetoprotein levels.
Cowchock FS; Jackson LG
Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
[TBL] [Abstract][Full Text] [Related]
16. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
[TBL] [Abstract][Full Text] [Related]
17. [Maternal serum AFP screening in type I diabetic patients].
Briese V
Zentralbl Gynakol; 1989; 111(10):664-8. PubMed ID: 2473582
[TBL] [Abstract][Full Text] [Related]
18. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
19. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
Widlund KF; Gottvall T
Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
[TBL] [Abstract][Full Text] [Related]
20. Role of fetal sex in amniotic fluid alphafetoprotein screening.
Knippel AJ
Prenat Diagn; 2002 Oct; 22(10):941-5. PubMed ID: 12378582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
